Translate
Camp4 Therapeutics Corporation
About
Camp4 Therapeutics Corporation (NASDAQ:CAMP) — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Calamos Brings Award-Winning Autocallable Income ETF Strategy to Global Investors with Launch of World's First Autocallable UCITS ETF
Mar 24 2026
CAMP4 Appoints Michael MacLean to its Board of Directors
Mar 6 2026
CAMP4 to Participate in Upcoming Investor Conferences
Mar 5 2026
CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
Jan 16 2026
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Recent Videos
GSKとCAMP4 Therapeuticsの大型提携を徹底解説：regRNAで遺伝子発現を「増強」する新潮流とは？ 抑制型RNA創薬との違い、狙う疾患領域、競合マップ、今後の注目ポイントまで
Jan 11, 2026
CURE SYNGAP1 Conference 2025: Science Day Session 4.4: ASO Therapy to Upregulate SYNGAP1 in SRD
Dec 30, 2025
🔥 Today’s NASDAQ BIOMEDICAL Stocks (December 10, 2025) 🔥
Dec 11, 2025
EP 195: From junk to therapy: The untapped power of regulatory RNAs with David Bumcrot of CAMP4 T...
Nov 19, 2025
Financials
Revenue
$3.5 M
Market Cap
$233.12 M
EPS
-2.65